Patents by Inventor Daniel R. Storm

Daniel R. Storm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7276345
    Abstract: The invention relates to novel human adenylyl cyclase nucleic acid and amino acid sequences. Also provided are vectors, host cells, recombinant methods for making and using the novel molecules and methods for identifying compounds which bind to the adenylyl cyclase proteins.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: October 2, 2007
    Assignees: Millennium Pharmaceuticals, Inc., University of Washington
    Inventors: Daniel R. Storm, Beth Hacker, James E. Tomlinson
  • Patent number: 6841372
    Abstract: A DNA sequence encoding a human adenylyl cyclase is described. The amino acid sequence of the adenylyl cyclase is also described.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: January 11, 2005
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Daniel R. Storm, Beth Hacker, James E. Tomlinson
  • Publication number: 20040013669
    Abstract: Disclosed is method of down-regulating an activity associated with AC1, AC8 or both in a subject comprising administering to the subject an antagonist to AC1, AC8 or both in an amount sufficient to affect the antagonism.
    Type: Application
    Filed: June 11, 2003
    Publication date: January 22, 2004
    Inventors: Feng Wei, Daniel R. Storm, Louis J. Muglia, Min Zhuo
  • Publication number: 20020137174
    Abstract: A DNA sequence encoding a human adenylyl cyclase is described.
    Type: Application
    Filed: February 11, 2002
    Publication date: September 26, 2002
    Applicant: COR Therapeutics, Inc.
    Inventors: Daniel R. Storm, Beth Hacker, James E. Tomlinson
  • Patent number: 6372475
    Abstract: A DNA sequence encoding a human adenylyl cyclase is described. The amino acid sequence of the adenylyl cyclase is also described.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: April 16, 2002
    Assignees: Cor Therapeutics Inc., University of Washington
    Inventors: Daniel R. Storm, Beth Hacker, James E. Tomlinson